Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Papillomavirus Infections 2Leiomyoma 2Inflammation 2Frailty 2Uterine Cervical Dysplasia 1Squamous Intraepithelial Lesions 1Radiodermatitis 1Liver Neoplasms 1Liver Cirrhosis 1Fibrosis 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Atypical Squamous Cells of the Cervix 1

Interventions

Specimen Handling 7Human Papillomavirus Recombinant Vaccine nonavalent 6Radiotherapy, Intensity-Modulated 5Human Papillomavirus DNA Tests 5Colposcopy 5Cisplatin 5Patient Navigation 3Methods 3Early Intervention, Educational 3Carboplatin 3human papillomavirus vaccine, L1 type 16, 18 2epigallocatechin gallate 2artesunic acid 2artemisinin 2Standard of Care 2Practice Guidelines as Topic 2Papillomavirus Vaccines 2Mass Screening 2Educational Status 2Docetaxel 2Cytological Techniques 2Blood Specimen Collection 2Biopsy 2toripalimab 1fludarabine phosphate 1fludarabine 1artenimol 1aldesleukin 1adacel 1Watchful Waiting 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Papillomavirus Infections × epigallocatechin gallate × 1 year × Clear all
NCT07572396 2026-05-14

Phase II Study of Dysplasixâ„¢ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

Amplexd Therapeutics, Inc.

Phase 2 Recruiting
45 enrolled
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

NCT06285357 2025-11-20

The Effect of the Association EGCG, Folic Acid and Vitamin B12 in Preventing the Persistence of HPV Infection.

Lo.Li.Pharma s.r.l

Phase NA Recruiting
100 enrolled

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡